AtaiBeckley (ATAI) EBT (2020 - 2026)
AtaiBeckley's quarterly EBT came in at -$29.8 million in Q1 2026, down 13.2% year-on-year from -$34.3 million in Q1 2025, and down 13.2% quarter-over-quarter from -$26.3 million in Q1 2025.
AtaiBeckley's EBT history runs 6 years deep, the most recent figure standing at -$61.0 million for Q3 2025.
- In Q3 2025, EBT fell 130.39% year-over-year to -$61.0 million; the TTM figure through Sep 2025 stood at -$154.1 million (down 20.83% YoY), while the FY2024 annual figure was -$148.4 million, down 277.76% from the prior year.
- EBT for Q1 2026 stood at -$29.8 million, down from -$26.3 million in the prior quarter.
- The five-year high for EBT was -$26.3 million in Q1 2025, with the low at -$29.8 million in Q1 2026.
- A 5-year average of -$30.2 million and a median of -$31.7 million in 2023 frame the typical range for EBT.
- Across the five-year window, EBT plunged 841.8% in 2021 and surged 232.33% in 2023, its largest moves.
- AtaiBeckley's EBT stood at -$48.6 million in 2021, then rose by 19.06% to -$39.3 million in 2022, then surged by 53.41% to -$18.3 million in 2023, then slumped by 113.89% to -$39.2 million in 2024, then plunged by 55.59% to -$61.0 million in 2025.
- According to Business Quant data, EBT over the past three periods registered -$61.0 million, -$27.7 million, and -$26.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 221.65 Mn |
| 10 | AtaiBeckley | 1.62 Bn | 1.62 Bn | - | -29.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.78 Mn |
| Sep 30, 2025 | -60.97 Mn |
| Jun 30, 2025 | -27.65 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Mar 31, 2025 | -26.31 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Sep 30, 2024 | -26.46 Mn |
| Jun 30, 2024 | -57.08 Mn |
| Mar 31, 2024 | -25.68 Mn |
| Dec 31, 2023 | -18.32 Mn |
| Sep 30, 2023 | 43.85 Mn |
| Jun 30, 2023 | -31.66 Mn |
| Mar 31, 2023 | -33.16 Mn |
| Dec 31, 2022 | -39.32 Mn |
| Sep 30, 2022 | -33.13 Mn |
| Jun 30, 2022 | -30.81 Mn |
| Mar 31, 2022 | -31.92 Mn |
| Dec 31, 2021 | -48.58 Mn |
| Sep 30, 2021 | -26.47 Mn |
| Jun 30, 2021 | -67.30 Mn |
| Mar 31, 2021 | 5.75 Mn |
| Dec 31, 2020 | -91.24 Mn |
| Sep 30, 2020 | -21.33 Mn |
| Jun 30, 2020 | -7.15 Mn |